Pediatric OCD and gut-brain microbiome links in kids on SSRIs
Official title: Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Run by Shanghai Mental Health Center · NCT06754319 · Data updated 2026-11-12
This study tests whether the gut microbiome and related markers change in children and teens with OCD when treated with SSRIs, and compares those results with kids who have OCD with tic disorders and healthy peers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 17 Years |
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | August 24, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT06754319 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 7-17 year-olds with OCD (with or without tic disorders), drug-naïve or off meds for 8 weeks, and an IQ of 80 or higher.
✕Probably not a fit
Patients with significant medical or neurological conditions, recent antibiotic or probiotic use, or poor response potential to SSRIs may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study analyzes the microbiota-gut-brain axis in pediatric OCD by integrating gut microbiota analysis, serum metabolomics, neuroimaging, and EEG before and after SSRI treatment. Participants include 7-17 year-olds with OCD, with or without tic disorders, and a healthy control group. The goal is to identify biomarkers and potential pathways that may contribute to OCD and to see how treatment influences these factors. Data will be used to explore possible new targets for intervention and to inform treatment optimization. The study is conducted at Shanghai Mental Health Center and is sponsored by the same institution.
Why it matters
Potential benefit: If successful, findings could help tailor future treatments by identifying microbiome-related targets and biomarkers.
How similar studies have gone: Similar approaches in related pediatric neuropsychiatric research have yielded insightful associations between microbiota and brain function, though direct causal links remain to be established in OCD.
Who can join: the full rules
Show full inclusion / exclusion criteria
We recruited outpatient children and adolescents with OCD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (4th edition). The following inclusion and exclusion criteria were also applied: Inclusion Criteria: (1) 7-17 years old, (2) Y-BOCS score ≥16, (3) with or without a history of TD, (4) Drug-naïve or drug-free for 8 weeks, (5) Wechsler IQ score ≥ 80. Exclusion Criteria: * History of serious medical, neurological illness or other psychotic disorders other than OCD (tic disorder excepted). * Previous exposure to cognitive behavioral therapy (CBT) for OCD or TD. * serious suicide risk. * Has taken antibiotics, probiotics, prebiotics, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants within the past 8 weeks. * Has a history of gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome, constipation, hemorrhoids, or a history of gastrointestinal surgery, or has a history of autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus. * Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
Where it's running
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Zhen Wang, PhD, MD — Shanghai Mental Health Center
- Study coordinator: Zhen Wang, PhD, MD
- Email: wangzhen@smhc.org.cn
- Phone: +86 34773516
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Tics and Tourette's: Accelerated TBS rTMS in Teens and Adults
This study tests whether a short, intensive course of inhibitory theta burst stimulation can help reduce tic symptoms in teens and young adults with Tourette syndrome or chronic tic disorders.
-
Mindfulness-Based Cognitive Therapy for OCD Delivered Online
This study tests a synchronous online MBCT program for adults with OCD to see if it is acceptable and feasible and to explore links between biological markers, OCD severity, and treatment response.
-
Targeted brain stimulation for OCD: test of tTIS on nucleus accumbens
This study tests whether targeted temporal interference stimulation of the nucleus accumbens can help reduce obsessive-compulsive symptoms in adults with OCD, compared with sham stimulation.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
AttunE LIFU for OCD: a non-invasive brain stimulation study
This trial tests ATTN201, a wearable ultrasound headband, to see if it helps adults with OCD compared to a sham treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.